What Can You Expect In 2026?
Protecting Biotech, Pharma, CRO & CDMO Workforces
As biopharma accelerates into 2026, EHS leaders are under unprecedented pressure to protect people while enabling innovation across radiopharmaceuticals, ADCs, cell and gene therapies, vaccines, and other emerging modalities. New facilities, unfamiliar hazards, tighter regulations, and workforce turnover are forcing organisations to rethink how EHS scales alongside scientific growth.
The 3rd Annual EHS in Biopharma Summit returns to Boston as the only industry-specific EHS meeting on the US East Coast dedicated exclusively to the realities of drug development. Designed for global, corporate, and site-level EHS leaders across biotech, pharma, CROs, and CDMOs, the summit brings together a high-calibre, senior speaker faculty actively shaping EHS strategy inside complex R&D and manufacturing environments.
Across three focused days, attendees gain practical, peer-driven insight into how leading organisations are:
- De-risking facilities handling novel and high-potency modalities
- Securing leadership buy-in for safety-minded culture at scale
- Applying AI, digitalisation, and data to move from reactive compliance to predictive safety
- Navigating OSHA, EPA, ABSA, CDC, and global regulatory complexity
- Embedding sustainability into waste, wastewater, and climate-ready operations
This is not a generic EHS event. Every session, workshop, and discussion is built around how safety actually works in biopharma, balancing scientific urgency with zero-harm expectations.
Unmissable Event Highlights
AI-Driven Safety Transformation: From Insight to Action
Explore how leading pharma and biotech companies are leveraging automation and AI to predict incidents, streamline compliance, and retain institutional knowledge. These sessions aim to bridge the gap between digital transformation and human oversight, featuring case studies and collaboration with Amgen, Thermo Fisher Scientific, and Zoetis.
Bridging the EHS Talent Gap in Biopharma
As EHS complexity grows with new modalities, the industry faces a critical shortage of skilled professionals. Learn from Pfizer, Sanofi, and Intellia Therapeutics as they share how they’re modernising training, building engagement, and turning compliance learning into true behavioural change.
Human-Centred Safety & Mental Health Integration
Discover how companies like AstraZeneca, Amgen, Ultragenyx, and Jackson Labs are redefining wellbeing - from ergonomic innovation and musculoskeletal disorder prevention to embedding psychological safety at every level of biopharma operations.
From Unknowns to Controls: Managing Risk in Emerging Modalities
Unpack the evolving risk frameworks for radiopharmaceuticals, ADCs, and novel biologics with experts from Sanofi, MannKind Corporation, and AbbVie. Gain insight into balancing unknown toxicology data, regulatory uncertainty, and practical containment design in real R&D and manufacturing settings.
Building Sustainable Biopharma Labs & Contractor Collaboration
Learn how Lab Central and Repligen are future-proofing facilities through adaptive design, unified contractor management, and responsible supply chain safety. Hear how flexible, ergonomic, and low-carbon labs are reshaping the future of safe, sustainable science.
Climate Action in High-Energy Environments
Tackle the toughest challenge in biopharma sustainability – decarbonising 24/7 operations. Learn practical pathways to reduce emissions, align with ISO standards, and translate ESG commitments into operational impact with Biogen.
Explore the Full Event Guide
- 25+ World Class Speakers with Unique Insights
- 4 Deep Dive Workshops
- 3 Data Driven AI Presentations
- 8+ Hours of Face-to-Face Networking Opportunities
- Interactive roundtables for peer discussion and benchmarking
Attending Companies Include
Explore the Agenda
Dive into the only agenda built by and for EHS leaders in biopharma. Gain practical takeaways from real-world case studies spanning R&D labs to large-scale manufacturing, and join interactive roundtables and workshops tackling today’s toughest challenges - from high-potency containment and AI-driven compliance to sustainable facility design and zero-harm culture.
Partner With Us
Stand alongside the most trusted EHS innovators in biopharma. Position your solutions where buying decisions happen - in front of global, corporate, and site-level leaders actively seeking new technologies, systems, and partners to drive safer, smarter, and more compliant operations.
Join Industry Experts
Connect directly with senior Environment, Health & Safety professionals shaping the future of biopharma. Exchange ideas with peers from top pharma, biotech, CRO and CDMO organisations, and build powerful collaborations during structured networking sessions designed to foster real partnerships and actionable insights.